Skip to main content

2026-05064

Regulation

Schedules of Controlled Substances: Temporary Placement of Bromazolam in Schedule I

Passed / Signedeconomy

Introduced: March 16, 2026

Progress

Summary

The Drug Enforcement Administration issues this temporary order to schedule 8-bromo-1-methyl-6-phenyl-4H- benzo[f][1,2,4]triazolo[4,3-a][l, 4]diazepine (commonly known as bromazolam), including its salts, isomers, and salts of isomers whenever the existence of such salts, isomers, and salts of isomers are possible, in schedule I of the Controlled Substances Act. DEA bases this action on a finding that placing bromazolam in schedule I is necessary to avoid an imminent hazard to public safety. This order imposes the regulatory controls and administrative, civil, and criminal sanctions applicable to schedule I controlled substances on persons who handle (manufacture, distribute, reverse distribute, import, export, engage in research, conduct instructional activities or chemical analysis, or possess) or propose to handle these substances.

How This Affects You

Sign up to see how this bill affects you personally

Already have an account? Log in

View on Federal Register

Get personalized insights on this bill

CivicRadar tells you exactly how government actions affect your life based on your location, interests, and profession.